UCB, a global biopharmaceutical company, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending ...

Lupin and TB Alliance join forces to advance Telacebec to treat tuberculosis and other mycobacterial diseases: Our Bureau, Mumbai Monday, February 2, 2026, 13:45 Hrs [IST] Global ...

EMA begins review of Tavneos, a medicine for rare autoimmune diseases GPA and MPA: Amsterdam, The Netherlands Monday, February 2, 2026, 14:00 Hrs [IST] European Medicines Agencys ...

NIH-supported investigators identify new blood markers that may detect early pancreatic cancer: Bethesda, Maryland Monday, February 2, 2026, 13:00 Hrs [IST] National Institutes of ...

Our Bureau, Bengaluru Monday, February 2, 2026, 13:30 Hrs [IST] Union Budget 2026 has buoyed sentiments among multinational pha ...

Our Bureau, Bengaluru Monday, February 2, 2026, 12:50 Hrs [IST] Union Budget 2026 has supercharged India’s healthcare sector, w ...

Healthcare leaders hail transformative 'BioPharma Shakti' & regional hub initiatives proposed in budget: Our Bureau, Chennai Monday, February 2, 2026, 13:15 Hrs [IST] The Union Bu ...

Pharma and health shine in budget 2026-27 with Rs. 1.05 lakh cr outlay and new Biopharma SHAKTI scheme: Our Bureau, Chennai Monday, February 2, 2026, 11:10 Hrs [IST] Finance Minis ...

Our Bureau, Bengaluru Monday, February 2, 2026, 11:20 Hrs [IST] ...

J&J receives CHMP positive opinion for Akeega to treat patients with metastatic hormone-sensitive prostate cancer with BRCA1/2 mutations: Beerse, Belgium Monday, February 2, 2026, ...

Global regulatory authorities reaffirm labelling as a high-impact tool to combat antimicrobial resistance: Geneva Monday, February 2, 2026, 11:00 Hrs [IST] Global regulatory leade ...

World RAPM Day workshop in Varanasi boosts patient safety standards in regional anaesthesia: Our Bureau, Chennai Monday, February 2, 2026, 12:15 Hrs [IST] In a significant move to ...